Glycosylation modulates melanoma cell α2β1 and α3β1 integrin interactions with type IV collagen

J Biol Chem. 2014 Aug 1;289(31):21591-604. doi: 10.1074/jbc.M114.572073. Epub 2014 Jun 23.

Abstract

Although type IV collagen is heavily glycosylated, the influence of this post-translational modification on integrin binding has not been investigated. In the present study, galactosylated and nongalactosylated triple-helical peptides have been constructed containing the α1(IV)382-393 and α1(IV)531-543 sequences, which are binding sites for the α2β1 and α3β1 integrins, respectively. All peptides had triple-helical stabilities of 37 °C or greater. The galactosylation of Hyl(393) in α1(IV)382-393 and Hyl(540) and Hyl(543) in α1(IV)531-543 had a dose-dependent influence on melanoma cell adhesion that was much more pronounced in the case of α3β1 integrin binding. Molecular modeling indicated that galactosylation occurred on the periphery of α2β1 integrin interaction with α1(IV)382-393 but right in the middle of α3β1 integrin interaction with α1(IV)531-543. The possibility of extracellular deglycosylation of type IV collagen was investigated, but no β-galactosidase-like activity capable of collagen modification was found. Thus, glycosylation of collagen can modulate integrin binding, and levels of glycosylation could be altered by reduction in expression of glycosylation enzymes but most likely not by extracellular deglycosylation activity.

Keywords: Collagen; Glycosylation; Hydroxylysine (Hyl); Integrins; Melanoma; Triple Helix.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Line, Tumor
  • Chromatography, High Pressure Liquid
  • Circular Dichroism
  • Collagen Type IV / metabolism*
  • Glycosylation
  • Humans
  • Integrin alpha2beta1 / metabolism*
  • Integrin alpha3beta1 / metabolism*
  • Melanoma / metabolism*
  • Models, Molecular
  • Protein Binding
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • Collagen Type IV
  • Integrin alpha2beta1
  • Integrin alpha3beta1